Sensei Biotherapeutics

Sensei Biotherapeutics

Sensei Biotherapeutics

Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.
Raised
$28.5M
Follow us
Latest funding
Team Size
1–10
Employees
Pulse 2.0

Sensei Biotherapeutics (SNSE) Stock: 30.11% Increase Explanation

$28,500,000 Undisclosed
FinSMEs

Sensei Biotherapeutics Raises $28.5M Financing